{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:28:23Z","timestamp":1757626103747,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Glutaric aciduria type I (GA-I) is an autosomal recessive disorder affecting the metabolism of lysine, hydroxylysine, and tryptophan. Patients present in the first age of life with an irreversible motor disorder, and neuroradiological imaging can suggest the presence of the condition. Biochemically, the disorder is characterized by elevated levels of glutaric and 3-hydroxy glutaric acid in the urine and glutarylcarnitine in the blood. This latter metabolite can be detected in dried blood spots, and the condition can therefore be included in some newborn screening programs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We present the case of a patient affected by GA-I that was undetected by newborn screening in whom the diagnosis was clinically oriented at the age of nine months by acute neurological symptoms, represented by persistent tonic seizures, and by neuroimaging showing bilateral signal alterations in the basal ganglia. Biochemical data, including glutarylcarnitine in dried blood spots and urinary excretion of glutaric acid, were normal in the acute phase and during follow-up. Molecular analysis confirmed a diagnosis of GA-I, showing a homozygous M405V variant of the <jats:italic>GCDH<\/jats:italic> gene, which is common in African populations and associated with a low-excretor phenotype characteristic of the disorder.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In conclusion, although GA-I is included in neonatal screening programs, the biochemical markers in dried blood spots can be absent. Therefore, in patients of African origin, clinicians should maintain a high degree of vigilance in the presence of suggestive clinical and neuroradiological findings, even if biochemical parameters are normal.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13052-025-01975-z","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T10:50:43Z","timestamp":1747133443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis of glutaric aciduria type I based on neuroradiological findings: when neonatal screening fails"],"prefix":"10.1186","volume":"51","author":[{"given":"Vincenza","family":"Gragnaniello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Puma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Gueraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio","family":"D\u2019Errico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Cazzorla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Loro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Porc\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Salviati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-137X","authenticated-orcid":false,"given":"Alberto B.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"1","key":"1975_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10545-006-0451-4","volume":"30","author":"S K\u00f6lker","year":"2007","unstructured":"K\u00f6lker S, Christensen E, Leonard JV, Greenberg CR, Burlina AB, Burlina AP, et al. Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis. 2007;30(1):5\u201322.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"1975_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10545-011-9289-5","volume":"34","author":"S K\u00f6lker","year":"2011","unstructured":"K\u00f6lker S, Christensen E, Leonard JV, Greenberg CR, Boneh A, Burlina AB, et al. Diagnosis and management of glutaric aciduria type I\u2013 revised recommendations. J Inher Metab Disea. 2011;34(3):677\u201394.","journal-title":"J Inher Metab Disea"},{"issue":"1","key":"1975_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10545-016-9999-9","volume":"40","author":"N Boy","year":"2017","unstructured":"Boy N, M\u00fchlhausen C, Maier EM, Heringer J, Assmann B, Burgard P, et al. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inher Metab Disea. 2017;40(1):75\u2013101.","journal-title":"J Inher Metab Disea"},{"issue":"6","key":"1975_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1023\/B:BOLI.0000045776.50573.52","volume":"27","author":"AP Burlina","year":"2004","unstructured":"Burlina AP, Zara G, Hoffmann GF, Zschocke J, Burlina AB. Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options. J Inherit Metab Dis. 2004;27(6):911\u20135.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1975_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10545-014-9676-9","volume":"37","author":"SF Garbade","year":"2014","unstructured":"Garbade SF, Greenberg CR, Demirkol M, G\u00f6k\u00e7ay G, Ribes A, Campistol J, et al. Unravelling the complex MRI pattern in glutaric aciduria type I using statistical models\u2014a cohort study in 180 patients. J Inher Metab Disea. 2014;37(5):763\u201373.","journal-title":"J Inher Metab Disea"},{"issue":"3","key":"1975_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ymgme.2018.08.006","volume":"125","author":"A Serrano Russi","year":"2018","unstructured":"Serrano Russi A, Donoghue S, Boneh A, Manara R, Burlina AB, Burlina AP. Malignant brain tumors in patients with glutaric aciduria type I. Mol Genet Metab. 2018;125(3):276\u201380.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1975_CR7","first-page":"12","volume":"58","author":"J Foran","year":"2021","unstructured":"Foran J, Moore M, Crushell E, Knerr I, McSweeney N. Low excretor glutaric aciduria type 1 of insidious onset with dystonia and atypical clinical features, a diagnostic dilemma. JIMD Rep. 2021;58(1):12\u201320.","journal-title":"JIMD Rep"},{"issue":"5","key":"1975_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ana.25233","volume":"83","author":"N Boy","year":"2018","unstructured":"Boy N, Mengler K, Thimm E, Schiergens KA, Marquardt T, Weinhold N, et al. Newborn screening: A disease-changing intervention for glutaric aciduria type 1. Ann Neurol. 2018;83(5):970\u20139.","journal-title":"Ann Neurol"},{"key":"1975_CR9","doi-asserted-by":"publisher","unstructured":"H\u00f6rster F, K\u00f6lker S, Loeber JG, Cornel MC, Hoffmann GF, Burgard P. Newborn Screening Programmes in Europe, Arguments and Efforts Regarding Harmonisation: Focus on Organic Acidurias. In: Morava E, Baumgartner M, Patterson M, Rahman S, Zschocke J, Peters V, editors. JIMD Reports, Volume 32 [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2016 [cited 2024 May 27]. pp. 105\u201315. (JIMD Reports; vol. 32). Available from: https:\/\/doi.org\/10.1007\/8904_2016_537","DOI":"10.1007\/8904_2016_537"},{"issue":"3","key":"1975_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/ijns8030047","volume":"8","author":"M Ruoppolo","year":"2022","unstructured":"Ruoppolo M, Malvagia S, Boenzi S, Carducci C, Dionisi-Vici C, Teofoli F, et al. Expanded newborn screening in Italy using tandem mass spectrometry: two years of National experience. IJNS. 2022;8(3):47.","journal-title":"IJNS"},{"issue":"1\u20132","key":"1975_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ymgme.2016.06.012","volume":"119","author":"LAP Schillaci","year":"2016","unstructured":"Schillaci LAP, Greene CL, Strovel E, Rispoli-Joines J, Spector E, Woontner M, et al. The M405V allele of the glutaryl-CoA dehydrogenase gene is an important marker for glutaric aciduria type I (GA-I) low excretors. Mol Genet Metab. 2016;119(1\u20132):50\u20136.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1975_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ymgme.2004.09.016","volume":"84","author":"S Tortorelli","year":"2005","unstructured":"Tortorelli S, Hahn SH, Cowan TM, Brewster TG, Rinaldo P, Matern D. The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I. Mol Genet Metab. 2005;84(2):137\u201343.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1975_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejpn.2006.11.006","volume":"11","author":"SH Korman","year":"2007","unstructured":"Korman SH, Jakobs C, Darmin PS, Gutman A, Van Der Knaap MS, Ben-Neriah Z, et al. Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel. Eur J Pediatr Neurol. 2007;11(2):81\u20139.","journal-title":"Eur J Pediatr Neurol"},{"issue":"5","key":"1975_CR14","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1542\/peds.107.5.1184","volume":"107","author":"WE Smith","year":"2001","unstructured":"Smith WE, Millington DS, Koeberl DD, Lesser PS. Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration. Pediatrics. 2001;107(5):1184\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"1975_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1023\/A:1024087832406","volume":"26","author":"EP Treacy","year":"2003","unstructured":"Treacy EP, Lee-Chong A, Roche G, Lynch B, Ryan S, Goodman S. Profound neurological presentation resulting from homozygosity for a mild glutaryl\u2010CoA dehydrogenase mutation with a minimal biochemical phenotype. J Inher Metab Disea. 2003;26(1):72\u20134.","journal-title":"J Inher Metab Disea"},{"issue":"3","key":"1975_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ymgme.2005.08.005","volume":"86","author":"RC Gallagher","year":"2005","unstructured":"Gallagher RC, Cowan TM, Goodman SI, Enns GM. Glutaryl-CoA dehydrogenase deficiency and newborn screening: retrospective analysis of a low excretor provides further evidence that some cases May be missed. Mol Genet Metab. 2005;86(3):417\u201320.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1975_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/ijns7020032","volume":"7","author":"J Spenger","year":"2021","unstructured":"Spenger J, Maier E, Wechselberger K, Bauder F, Kocher M, Sperl W, et al. Glutaric aciduria type I missed by newborn screening: report of four cases from three families. IJNS. 2021;7(2):32.","journal-title":"IJNS"},{"issue":"1","key":"1975_CR18","first-page":"67","volume":"60","author":"AJ Guenzel","year":"2021","unstructured":"Guenzel AJ, Hall PL, Scott AI, Lam C, Chang IJ, Thies J, et al. The low excretor phenotype of glutaric acidemia type I is a source of false negative newborn screening results and challenging diagnoses. JIMD Rep. 2021;60(1):67\u201374.","journal-title":"JIMD Rep"},{"issue":"7","key":"1975_CR19","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1093\/brain\/awp112","volume":"132","author":"I Harting","year":"2009","unstructured":"Harting I, Neumaier-Probst E, Seitz A, Maier EM, Assmann B, Baric I, et al. Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain. 2009;132(7):1764\u201382.","journal-title":"Brain"},{"issue":"8","key":"1975_CR20","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1023\/A:1005683222187","volume":"22","author":"I Baric","year":"1999","unstructured":"Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF. Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope Dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis. 1999;22(8):867\u201381.","journal-title":"J Inherit Metab Dis"},{"issue":"16","key":"1975_CR21","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/mds.22313","volume":"23","author":"C Gitiaux","year":"2008","unstructured":"Gitiaux C, Roze E, Kinugawa K, Flamand-Rouvi\u00e8re C, Boddaert N, Apartis E, et al. Spectrum of movement disorders associated with glutaric aciduria type 1: A study of 16 patients. Mov Disord. 2008;23(16):2392\u20137.","journal-title":"Mov Disord"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01975-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01975-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01975-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:44:43Z","timestamp":1757450683000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01975-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1975"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01975-z","relation":{},"ISSN":["1824-7288"],"issn-type":[{"type":"electronic","value":"1824-7288"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not requested for case report (University Hospital of Padua Ethics Committees).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the parents of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}